Inventor · disambiguated record
Mark R. Burns
Also filed as: BURNS MARK R · BURNS MARK ROBERT
21 granted patents·6 pending applications·232 citations·filing 1996–2022
95Inventor score
Files withMEDIQUEST THERAPEUTICS INC12AMINEX THERAPEUTICS INC6UNIV KANSAS3Aminex Therapeutics2BURNS MARK R1
Top patents by PatentIndex Score
27 records- 0191US10632145B2Bioavailable polyaminesAMINEX THERAPEUTICS INC·Filed 2017·Granted Apr 28, 2020·4 cites·12 claims
- 0290US11395834B2Bioavailable polyaminesAMINEX THERAPEUTICS INC·Filed 2020·Granted Jul 26, 2022·2 cites·16 claims
- 0390US7199267B1Recognition of oligiosaccaride molecular targets by polycationic small molecule inhibitors and treatment of immunological disorders and infectious diseasesUNIV KANSAS·Filed 2005·Granted Apr 3, 2007·8 cites·10 claims
- 0489US7411002B2Polycationic sulfonamides and use thereofUNIV KANSAS·Filed 2006·Granted Aug 12, 2008·9 cites·18 claims
- 0588US11865095B2Combination drug substance of polyamine transport inhibitor and DFMOAMINEX THERAPEUTICS INC·Filed 2021·Granted Jan 9, 2024·1 cites·22 claims
- 0687US7432302B2Composition containing polyamine transport inhibitor and use thereofMEDIQUEST THERAPEUTICS INC·Filed 2005·Granted Oct 7, 2008·8 cites·9 claims
- 0786US7160923B1Polyamine analogues as therapeutic and diagnostic agentsMEDIQUEST THERAPEUTICS INC·Filed 2000·Granted Jan 9, 2007·16 cites·49 claims
- 0886US6172261B1Polyamine analogues as therapeutic and diagnostic agentsORIDIGM CORP·Filed 1998·Granted Jan 9, 2001·67 cites·24 claims
- 0983US7388112B2Immunomodulation with novel pharmaceutical compositionsMEDIQUEST THERAPEUTICS INC·Filed 2005·Granted Jun 17, 2008·7 cites·16 claims
- 1080US6646149B1Polyamine analogues as therapeutic and diagnostic agentsFiled 2000·Granted Nov 11, 2003·18 cites·28 claims
- 1179US12364709B2Bioavailable poly aminesAMINEX THERAPEUTICS INC·Filed 2022·Granted Jul 22, 2025·0 cites·8 claims
- 1279US6963010B2Hydrophobic polyamine analogs and methods for their useMEDIQUEST THERAPEUTICS INC·Filed 2002·Granted Nov 8, 2005·12 cites·16 claims
- 1379US6919483B2Immunomodulation with novel pharmaceutical compositionsMEDIQUEST THERAPEUTICS INC·Filed 2003·Granted Jul 19, 2005·13 cites·18 claims
- 1479US6872852B2Polyamine analogues as cytotoxic agentsMEDIQUEST THERAPEUTICS INC·Filed 2001·Granted Mar 29, 2005·11 cites·13 claims
- 1573US7662999B2Recognition of oligosaccharide molecular targets by polycationic small molecule inhibitors and treatment of immunological disorders and infectious diseasesMEDIQUEST THERAPEUTICS INC·Filed 2007·Granted Feb 16, 2010·1 cites·7 claims
- 1670US7144920B2Polyamine analogs that activate antizyme frameshiftingMEDIQUEST THERAPEUTICS INC·Filed 2004·Granted Dec 5, 2006·5 cites·9 claims
- 1770US6914079B2Polyamine analogs that activate antizyme frameshiftingMEDIQUEST THERAPEUTICS INC·Filed 2002·Granted Jul 5, 2005·5 cites·8 claims
- 1869USRE43327EHydrophobic polyamine analogs and methods for their useBURNS MARK R·Filed 2002·Granted Apr 24, 2012·7 cites·24 claims
- 1962US2023321012A1Methods To Treat Cancer With AMXT 1501 and DFMOAMINEX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2055US5812590AFrequency spreading clock modulationMOTOROLA INC·Filed 1996·Granted Sep 22, 1998·22 cites·15 claims
- 2153US7232831B2Tetrahydro-β-carboline compounds and use thereofMEDIQUEST THERAPEUTICS INC·Filed 2004·Granted Jun 19, 2007·0 cites·11 claims
- 2253US7208528B1Polyamine analogues as therapeutic and diagnostic agentsMEDIQUEST THERAPEUTICS INC·Filed 1999·Granted Apr 24, 2007·16 cites·19 claims
- 2353US2015050299A1Methods for enhancing immune responseAminex Therapeutics·Filed 2014·Application pending·0 cites
- 2449US2013164328A1Methods for enhancing immune responseAminex Therapeutics·Filed 2013·Application pending·0 cites
- 2548US2005176828A1Hydrophobic polyamine analogs and methods for their useMEDIQUEST THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 2645US2011256161A1Methods for enhancing immune responseAMINEX THERAPEUTICS INC·Filed 2011·Application pending·0 cites
- 2743US2006122279A1Hydrophobic polyamine amides as potent lipopolysaccharide sequestrantsUNIV KANSAS·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →